NRBO logo

NeuroBo Pharmaceuticals (NRBO) Free Cash Flow

Annual FCF

-$10.85 M
+$863.00 K+7.37%

December 31, 2023

Summary

Performance

1-Year Change

+7.37%

3-Year Change

-0.75%

5-Year Change

+24.94%

15-Year Change

+59.67%

NRBO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.31%
NRBO annual free cash flow is higher than 61.31% of companies in Healthcare sector

High & Low

All-time High

-$195.00 K

3-Year Low

-$15.14 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NRBO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 9, 2025
NRBO next annual earnings announcement is scheduled for May 9, 2025

OtherNRBOcash flowmetrics:

Annual CFO

-$10.80 M
NRBO annual cash flow from operations is -$10.80 million

Annual CFF

-$80.00 K
NRBO annual cash flow from financing activities is -$80.00 thousand

Annual CFI

-$50.00 K
NRBO annual cash flow from investing activities is -$50.00 thousand

Annual CAPEX

-
NRBO annual capital expenditures value is unknown

Quarterly FCF

-$5.59 M
+$1.67 M+22.95%

September 30, 2024

Summary

Performance

3-Month Change

+22.95%

1-Year Change

-64.29%

3-Year Change

-122.94%

5-Year Change

-62.57%

NRBO Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.78%
NRBO quarterly free cash flow is higher than 45.78% of companies in Healthcare sector

High & Low

All-time High

$3.35 M
NRBO quarterly free cash flow is currently -266.99% below its historical high of $3.35 million

3-Year Low

-$7.25 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NRBO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 9, 2025
NRBO next earnings announcement is scheduled for May 9, 2025

OtherNRBOcash flowmetrics:

Quarterly CFO

-$5.59 M
NRBO quarterly cash flow from operations is -$5.59 million

Quarterly CFF

-$676.00 K
NRBO quarterly cash flow from financing activities is -$676.00 thousand

Quarterly CFI

$0.00
NRBO quarterly cash flow from investing activities is $0.00

Quarterly CAPEX

-
NRBO quarterly capital expenditures value is unknown

TTM FCF

-$22.69 M
-$2.74 M-13.72%

September 30, 2024

Summary

Performance

3-Month Change

-13.72%

1-Year Change

-109.16%

3-Year Change

-55.55%

5-Year Change

-212.86%

NRBO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.17%
NRBO TTM free cash flow is higher than 45.17% of companies in Healthcare sector

High & Low

All-time High

-$620.00 K

3-Year Low

-$22.69 M
NRBO TTM free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NRBO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 9, 2025
NRBO next earnings announcement is scheduled for May 9, 2025

OtherNRBOcash flowmetrics:

TTM CFO

-$22.68 M
NRBO TTM cash flow from operations is -$22.68 million

TTM CFF

$18.52 M
NRBO TTM cash flow from financing activities is $18.52 million

TTM CFI

-$17.00 K
NRBO TTM cash flow from investing activities is -$17.00 thousand

TTM CAPEX

-
NRBO TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$10.85 M
NRBO annual free cash flow is -$10.85 million

Annual CFO

-$10.80 M
NRBO annual cash flow from operations is -$10.80 million

Annual CAPEX

-
NRBO annual capital expenditures value is unknown

NRBO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.4%-64.3%-109.2%
3 y3 years-0.8%-122.9%-55.5%
5 y5 years+24.9%-62.6%-212.9%

NRBO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+28.3%-209.3%+22.9%-159.0%at low
5 y5-year-49.6%+28.3%-306.8%+22.9%-212.9%at low
alltimeall time-5463.6%+59.7%-267.0%+23.4%-3560.0%+18.7%

NeuroBo Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.59 M(-23.0%)
-$22.69 M(+13.7%)
Jun 2024
-
-$7.25 M(+12.5%)
-$19.95 M(+35.3%)
Mar 2024
-
-$6.45 M(+89.5%)
-$14.74 M(+35.9%)
Dec 2023
-$10.85 M(-7.4%)
-$3.40 M(+19.3%)
-$10.85 M(+17.2%)
Sep 2023
-
-$2.85 M(+39.4%)
-$9.25 M(+5.6%)
Jun 2023
-
-$2.04 M(-19.8%)
-$8.76 M(-7.1%)
Mar 2023
-
-$2.55 M(+41.2%)
-$9.43 M(-19.5%)
Dec 2022
-$11.71 M(-22.6%)
-$1.81 M(-23.4%)
-$11.71 M(-8.5%)
Sep 2022
-
-$2.36 M(-13.2%)
-$12.80 M(-1.1%)
Jun 2022
-
-$2.72 M(-43.7%)
-$12.95 M(-6.3%)
Mar 2022
-
-$4.83 M(+66.6%)
-$13.82 M(-8.7%)
Dec 2021
-$15.14 M(+40.6%)
-$2.90 M(+15.6%)
-$15.14 M(+3.8%)
Sep 2021
-
-$2.51 M(-30.2%)
-$14.59 M(+3.9%)
Jun 2021
-
-$3.59 M(-41.5%)
-$14.04 M(+9.9%)
Mar 2021
-
-$6.14 M(+161.3%)
-$12.77 M(+18.6%)
Dec 2020
-$10.77 M(+48.5%)
-$2.35 M(+20.3%)
-$10.77 M(+10.0%)
Sep 2020
-
-$1.95 M(-15.9%)
-$9.79 M(-13.2%)
Jun 2020
-
-$2.32 M(-43.9%)
-$11.28 M(+10.9%)
Mar 2020
-
-$4.14 M(+201.3%)
-$10.17 M(+40.2%)
Dec 2019
-$7.25 M
-$1.37 M(-60.0%)
-$7.25 M(+186.5%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$3.44 M(+182.5%)
-$2.53 M(-25.0%)
Jun 2019
-
-$1.22 M(-0.6%)
-$3.38 M(-60.0%)
Mar 2019
-
-$1.22 M(-136.6%)
-$8.44 M(-41.6%)
Dec 2018
-$14.45 M(-46.3%)
$3.35 M(-178.1%)
-$14.45 M(-41.2%)
Sep 2018
-
-$4.28 M(-31.8%)
-$24.56 M(-10.9%)
Jun 2018
-
-$6.28 M(-13.2%)
-$27.57 M(-1.2%)
Mar 2018
-
-$7.24 M(+7.0%)
-$27.91 M(+3.8%)
Dec 2017
-$26.90 M(+143.6%)
-$6.76 M(-7.4%)
-$26.90 M(+13.2%)
Sep 2017
-
-$7.30 M(+10.3%)
-$23.76 M(+18.2%)
Jun 2017
-
-$6.62 M(+6.4%)
-$20.10 M(+32.1%)
Mar 2017
-
-$6.22 M(+71.8%)
-$15.21 M(+37.7%)
Dec 2016
-$11.04 M(+103.3%)
-$3.62 M(-0.3%)
-$11.04 M(+14.1%)
Sep 2016
-
-$3.63 M(+110.1%)
-$9.68 M(+27.2%)
Jun 2016
-
-$1.73 M(-15.9%)
-$7.60 M(+10.7%)
Mar 2016
-
-$2.06 M(-8.9%)
-$6.87 M(+26.4%)
Dec 2015
-$5.43 M(+2686.2%)
-$2.26 M(+44.4%)
-$5.43 M(+71.0%)
Sep 2015
-
-$1.56 M(+57.0%)
-$3.18 M(+96.7%)
Jun 2015
-
-$995.00 K(+60.5%)
-$1.61 M(+160.5%)
Mar 2015
-
-$620.00 K
-$620.00 K
Dec 2014
-$195.00 K
-
-

FAQ

  • What is NeuroBo Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for NeuroBo Pharmaceuticals?
  • What is NeuroBo Pharmaceuticals annual FCF year-on-year change?
  • What is NeuroBo Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for NeuroBo Pharmaceuticals?
  • What is NeuroBo Pharmaceuticals quarterly FCF year-on-year change?
  • What is NeuroBo Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for NeuroBo Pharmaceuticals?
  • What is NeuroBo Pharmaceuticals TTM FCF year-on-year change?

What is NeuroBo Pharmaceuticals annual free cash flow?

The current annual FCF of NRBO is -$10.85 M

What is the all time high annual FCF for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals all-time high annual free cash flow is -$195.00 K

What is NeuroBo Pharmaceuticals annual FCF year-on-year change?

Over the past year, NRBO annual free cash flow has changed by +$863.00 K (+7.37%)

What is NeuroBo Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of NRBO is -$5.59 M

What is the all time high quarterly FCF for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals all-time high quarterly free cash flow is $3.35 M

What is NeuroBo Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, NRBO quarterly free cash flow has changed by -$2.19 M (-64.29%)

What is NeuroBo Pharmaceuticals TTM free cash flow?

The current TTM FCF of NRBO is -$22.69 M

What is the all time high TTM FCF for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals all-time high TTM free cash flow is -$620.00 K

What is NeuroBo Pharmaceuticals TTM FCF year-on-year change?

Over the past year, NRBO TTM free cash flow has changed by -$11.84 M (-109.16%)